It has been demonstrated that IGF1R inhibitors could inhibit proliferation and promote apoptosis, even with alleviation of mitotane-associated cytotoxicity in ACC cell lines [6, 9]. The gene discussed is IGF1R; the disease is adrenal cortex carcinoma.